Elevated expression of orexin receptor 2 (HCRTR2) in benign prostatic hyperplasia is accompanied by lowered serum orexin A concentrations

Author：          

Publisher： Spandidos Publications

ISSN： 1107-3756

Source： International Journal of Molecular Medicine, Vol.27, Iss.3, 2011-01, pp. : 377-383

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

OREXIN 1 AND 2 RECEPTOR INVOLVEMENT IN CO2‐INDUCED PANIC‐ASSOCIATED BEHAVIOR AND AUTONOMIC RESPONSES

By  

DEPRESSION AND ANXIETY (ELECTRONIC), Vol. 32, Iss. 9, 2015-09 ,pp. : 671-683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Osteopontin Expression in Prostate Cancer and Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 62, Iss. 3, 1999-10 ,pp. : 155-158

Karger

Access to resources Recommend Favorite

Interstitial Laser Coagulation in Benign Prostatic Hyperplasia: A Critical Evaluation after 2 Years of Follow-Up

By  

Urologia Internationalis, Vol. 62, Iss. 2, 1999-08 ,pp. : 76-80

Karger

Access to resources Recommend Favorite

Tadalafil Monotherapy for Benign Prostatic Hyperplasia

By  

Urologia Internationalis, Vol. 91, Iss. 4, 2013-08 ,pp. : 487-488

Karger

Access to resources Recommend Favorite

Benign Prostatic Hyperplasia: Diagnosis and Treatment

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 46, Iss. 9, 1998-09 ,pp. : 1163-1165

John Wiley & Sons Inc

Access to resources Recommend Favorite